Table 1. Pandemic vaccine uptake among ILI cases included in the pandemic vaccine effectiveness analysis.
Epidemic study period | Post-epidemic study period | |||||||||
Vaccinated for | Vaccinated for | |||||||||
Age group | Total described | Total vaccinated | >3 weeks | Unknown | ≤3 weeks | Total described | Total vaccinated | >3 weeks | Unknown | ≤3 weeks |
6 m–4 y | 875 | 43 | 13 | 1 | 29 | 51 | 5 | 4 | 1 | 0 |
5–14 | 2740 | 44 | 6 | 4 | 34 | 89 | 9 | 7 | 0 | 2 |
15–24 | 1250 | 13 | 1 | 2 | 10 | 55 | 2 | 2 | 0 | 0 |
25–34 | 763 | 7 | 1 | 0 | 6 | 80 | 3 | 3 | 0 | 0 |
35–49 | 937 | 19 | 2 | 0 | 17 | 135 | 11 | 11 | 0 | 0 |
50–64 | 378 | 8 | 1 | 0 | 7 | 68 | 6 | 5 | 0 | 1 |
65–69 | 46 | 0 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 0 |
70–74 | 28 | 2 | 0 | 0 | 2 | 10 | 0 | 0 | 0 | 0 |
≥75 | 55 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 |
Total | 7072 | 136 | 24 | 7 | 105 | 514 | 36 | 32 | 1 | 3 |